Guowang Xu
Geciteerd door
Geciteerd door
Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
R Liu, J Hong, X Xu, Q Feng, D Zhang, Y Gu, J Shi, S Zhao, W Liu, ...
Nature medicine 23 (7), 859-868, 2017
Altered lipid metabolism in recovered SARS patients twelve years after infection
Q Wu, L Zhou, X Sun, Z Yan, C Hu, J Wu, L Xu, X Li, H Liu, P Yin, K Li, ...
Scientific reports 7 (1), 9110, 2017
Mass spectrometry-based metabolomics: A guide for annotation, quantification and best reporting practices
S Alseekh, A Aharoni, Y Brotman, K Contrepois, J D’Auria, J Ewald, ...
Nature methods 18 (7), 747-756, 2021
Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics
Q Huang, Y Tan, P Yin, G Ye, P Gao, X Lu, H Wang, G Xu
Cancer research 73 (16), 4992-5002, 2013
Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and …
C Wang, H Kong, Y Guan, J Yang, J Gu, S Yang, G Xu
Analytical chemistry 77 (13), 4108-4116, 2005
Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
Y Gu, X Wang, J Li, Y Zhang, H Zhong, R Liu, D Zhang, Q Feng, X Xie, ...
Nature communications 8 (1), 1785, 2017
Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases
J Yang, G Xu, Y Zheng, H Kong, T Pang, S Lv, Q Yang
Journal of Chromatography B 813 (1-2), 59-65, 2004
A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
P Luo, P Yin, R Hua, Y Tan, Z Li, G Qiu, Z Yin, X Xie, X Wang, W Chen, ...
Hepatology 67 (2), 662-675, 2018
Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus
X Li, Z Xu, X Lu, X Yang, P Yin, H Kong, Y Yu, G Xu
Analytica Chimica Acta 633 (2), 257-262, 2009
Preanalytical aspects and sample quality assessment in metabolomics studies of human blood
P Yin, A Peter, H Franken, X Zhao, SS Neukamm, L Rosenbaum, M Lucio, ...
Clinical chemistry 59 (5), 833-845, 2013
Effects of pre-analytical processes on blood samples used in metabolomics studies
P Yin, R Lehmann, G Xu
Analytical and bioanalytical chemistry 407, 4879-4892, 2015
Relationship of serum trimethylamine N-oxide (TMAO) levels with early atherosclerosis in humans
E Randrianarisoa, A Lehn-Stefan, X Wang, M Hoene, A Peter, ...
Scientific reports 6 (1), 26745, 2016
Analytical strategies in lipidomics and applications in disease biomarker discovery
C Hu, R van der Heijden, M Wang, J van der Greef, T Hankemeier, G Xu
Journal of Chromatography B 877 (26), 2836-2846, 2009
Characterization of flavor compounds in Chinese liquor Moutai by comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry
S Zhu, X Lu, K Ji, K Guo, Y Li, C Wu, G Xu
Analytica chimica acta 597 (2), 340-348, 2007
Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits
X Zhao, J Fritsche, J Wang, J Chen, K Rittig, P Schmitt-Kopplin, A Fritsche, ...
Metabolomics 6, 362-374, 2010
Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations
J Chen, W Wang, S Lv, P Yin, X Zhao, X Lu, F Zhang, G Xu
Analytica Chimica Acta 650 (1), 3-9, 2009
A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry
P Yin, D Wan, C Zhao, J Chen, X Zhao, W Wang, X Lu, S Yang, J Gu, ...
Molecular BioSystems 5 (8), 868-876, 2009
LC–MS-based metabonomics analysis
X Lu, X Zhao, C Bai, C Zhao, G Lu, G Xu
Journal of Chromatography B 866 (1-2), 64-76, 2008
Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics
Y Gu, Y Zhang, X Shi, X Li, J Hong, J Chen, W Gu, X Lu, G Xu, G Ning
Talanta 81 (3), 766-772, 2010
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
Y Zhang, Y Gu, H Ren, S Wang, H Zhong, X Zhao, J Ma, X Gu, Y Xue, ...
Nature communications 11 (1), 5015, 2020
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20